Peficitinib
Showing 1 - 25 of 33
Healthy Volunteers Trial in Beijing (peficitinib)
Completed
- Healthy Volunteers
- peficitinib
-
Beijing, ChinaSite CN86001
Dec 9, 2021
Rheumatoid Arthritis (RA) Trial in China, Korea, Republic of, Taiwan (Peficitinib, Plaebo, Disease-modifying antirheumatic drugs
Completed
- Rheumatoid Arthritis (RA)
- Peficitinib
- +2 more
-
Anhui, China
- +42 more
Jan 7, 2023
Healthy Volunteers Trial in Tokyo (peficitinib)
Completed
- Healthy Volunteers
- peficitinib
-
Tokyo, Japan(unnamed)
Sep 13, 2019
Pharmacokinetics of ASP015K, Healthy Volunteer Trial in Kyushu (peficitinib, Placebo)
Completed
- Pharmacokinetics of ASP015K
- Healthy Volunteer
- peficitinib
- Placebo
-
Kyushu, Japan(unnamed)
Sep 11, 2019
Arthritis, Rheumatoid Trial in Japan (peficitinib, Placebo)
Completed
- Arthritis, Rheumatoid
- peficitinib
- Placebo
-
Chubu, Japan
- +6 more
Jul 9, 2019
Psoriasis Trial in United States (peficitinib, Placebo)
Completed
- Psoriasis
- peficitinib
- Placebo
-
Birmingham, Alabama
- +10 more
Jun 6, 2019
Rheumatoid Arthritis Trial in Japan (Peficitinib, Placebo, Methotrexate)
Completed
- Rheumatoid Arthritis
- Peficitinib
- +2 more
-
Nagoya, Aichi, Japan
- +145 more
Jul 16, 2020
Ulcerative Colitis, Thromboembolism Trial in Madrid (Tofacitinib, Infliximab Adalimumab y Golimumab)
Recruiting
- Ulcerative Colitis
- Thromboembolism
- Tofacitinib
- Infliximab Adalimumab y Golimumab
-
Madrid, SpainHospital Universitario de La Princesa
Aug 2, 2022
Rheumatoid Arthritis Trial in Japan, Korea, Republic of, Taiwan (Peficitinib, Placebo, Etanercept)
Completed
- Rheumatoid Arthritis
- Peficitinib
- +2 more
-
Nagoya, Aichi, Japan
- +152 more
Mar 1, 2020
Arthritis, Rheumatoid Trial in Worldwide (peficitinib, Placebo)
Completed
- Arthritis, Rheumatoid
- peficitinib
- Placebo
-
Birmingham, Alabama
- +37 more
May 29, 2019
Arthritis, Rheumatoid Trial in Worldwide (peficitinib)
Completed
- Arthritis, Rheumatoid
- peficitinib
-
Birmingham, Alabama
- +50 more
May 20, 2019
Arthritis, Rheumatoid Trial in Worldwide (peficitinib, Placebo, methotrexate)
Completed
- Arthritis, Rheumatoid
- peficitinib
- +2 more
-
Birmingham, Alabama
- +48 more
May 29, 2019
Colitis, Ulcerative Trial in Worldwide (Placebo, JNJ-54781532 25 mg once daily, JNJ-54781532 75 mg once daily)
Completed
- Colitis, Ulcerative
- Placebo
- +4 more
-
La Jolla, California
- +101 more
Jan 3, 2019
Pharmacokinetics of ASP015K, Food Effect, Healthy Volunteers Trial in Baltimore (ASP015K ER, ASP015K IR)
Completed
- Pharmacokinetics of ASP015K
- +2 more
- ASP015K ER
- ASP015K IR
-
Baltimore, MarylandParexel International
Aug 31, 2015
Healthy Volunteers, Pharmacokinetics of ASP015K Trial in Glendale (ASP015K, Placebo)
Completed
- Healthy Volunteers
- Pharmacokinetics of ASP015K
- ASP015K
- Placebo
-
Glendale, CaliforniaCalifornia Clinical Trials Medical Group/Parexel
Jun 2, 2014
Healthy Subjects, Pharmacokinetics of ASP015K Trial in Glendale (ASP015K, Rosuvastatin)
Completed
- Healthy Subjects
- Pharmacokinetics of ASP015K
-
Glendale, CaliforniaPAREXEL - Early Phase Unit
Oct 8, 2013
Bioavailability of ASP015K, Healthy Subjects, Pharmacokinetics of ASP015K Trial in Baltimore (ASP015K)
Completed
- Bioavailability of ASP015K
- +3 more
-
Baltimore, MarylandParexel - Early Phase Clinical Unit
Sep 13, 2013